AI assistant
BIO-TECHNE Corp — Director's Dealing 2019
Aug 9, 2019
30718_dirs_2019-08-09_6753bdf0-e3cd-44a7-afc8-f05b2f4251fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-08-07
Reporting Person: Eansor Norman David (SVP - Novus Biologicals)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-07 | Restricted Stock Units | $ | A | 3151 | Acquired | Common Stock (3151) | Direct | |
| 2019-08-07 | Stock Options (Right to Buy) | $190.41 | A | 15948 | Acquired | 2026-08-07 | Common Stock (15948) | Direct |
| 2019-08-07 | Stock Options (Right to Buy) | $190.41 | A | 21265 | Acquired | 2026-08-07 | Common Stock (21265) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $94.35 | 2021-08-12 | Common Stock (15000) | 15000 | Direct |
| Stock Options (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (12500) | 12500 | Direct |
| Stock Options (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (7494) | 7494 | Direct |
| Restricted Stock Units | $ | Common Stock (2287) | 2287 | Direct | |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (14114) | 14114 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (18819) | 18819 | Direct |
| Restricted Stock Units | $ | Common Stock (2174) | 2174 | Direct | |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (11982) | 11982 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (15976) | 15976 | Direct |
| Restricted Stock Units | $ | Common Stock (2537) | 2537 | Direct | |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (13550) | 13550 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (18066) | 18066 | Direct |
Footnotes
F1: Fully exercisable.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3: Vests in full or in part on 8/18/2019 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F4: Options to purchase 4,705 shares vest on each of 8/18/2017, 8/18/2018 and 8/18/2019 and options to purchase 4,704 shares vest on 8/18/2020.
F5: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 3,994 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021.
F7: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Options to purchase 4,517 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 4,516 shares vest on each of 8/8/2021 and 8/8/2022.
F9: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Options to purchase 5,317 shares vest on 8/7/2020 and options to purchase 5,316 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.